LYEL

LYELL IMMUNOPHARMA INC

LYEL·55083R203·US·Common Stock·Healthcare - Biotechnology-13D/G

LYEL (LYELL IMMUNOPHARMA INC) is held by 57 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($11.1M), BlackRock, Inc. ($10.2M), MILLENNIUM MANAGEMENT LLC ($5.2M). Net institutional sentiment: Bullish.

57
Holders
(3 Elite)
$57.2M
Total Value
67% (55)
Consensus
37 buying - 18 selling
13F: Insider & Congress: Updated regularly
LYEL

Smart Money Verdict

View all
Loading verdict
Held by 57 funds
3 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 25, 2026 · Activists Aug 14, 2026 · Congress none

InsiderLKLee Gary K.Sell $23KAug 21, 2026
InsiderHJHill Stephen J.Sell $15KAug 21, 2026
InsiderSLSeely LynnSell $149KAug 21, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
786,774(+9.6%)$11.1M0.0%-34.28%
30
Increased
724,342(+277.6%)$10.2M0.0%+5.61%
45
Decreased
367,473(-19.9%)$5.2M0.0%-35.84%
0
Increased
310,636(+86.0%)$4.4M0.0%-71.17%
42
Unchanged
293,256$4.1M0.0%-78.67%
0
Increased
185,322(+155.5%)$2.6M0.0%-30.39%
42
Increased
130,190(+11.8%)$1.8M0.0%-25.81%
29
Increased
118,500(+291.4%)$1.7M0.0%-56.04%
41
Increased
110,531(+100.6%)$1.6M0.0%-23.53%
41
Increased
107,570(+25.1%)$1.5M0.0%-77.49%
31
Decreased
106,300(-28.4%)$1.5M0.0%-46.00%
0
Increased
93,095(+7.1%)$1.3M0.0%-34.84%
27
Increased
91,891(+299.3%)$1.3M0.0%-9.61%
41
Decreased
86,779(-24.2%)$1.2M0.0%-51.16%
0
Increased
68,315(+42.7%)$957,0660.0%-28.00%
34
Increased
52,927(+356.9%)$743,6240.0%-5.22%
40
Decreased
46,011(-28.0%)$646,4550.0%-40.64%
0
Increased
42,322(+119.3%)$594,6240.0%-19.04%
39
Decreased
37,050(-34.0%)$520,5530.0%-42.00%
0
Unchanged
29,411$413,2250.0%-95.09%
0

Showing 1-20 of 61

1 / 4
LYELLYELLYELL IMMUNOPHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used